LOS ANGELES (KABC) -- Stage 4 prostate cancer patients can benefit the most from a triple combination therapy, studies show. But doctors say the most essential part of treating men with this dire ...
Adding chemotherapy and bevacizumab to immunotherapy improves tumor control in a high-risk CRC subset, but this benefit comes ...
CEO Koenig reported momentum in early Q2 2025, with prescription volumes tracking approximately 8% higher than Q1 levels. The company aims to commercialize a triple combination therapy by 2027, ...
In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance. A team of researchers found that combinations of ...
Multi-mechanism, triple combination of existing best-in-class medicines in novel low dose single pill, GMRx2 has potential to be the only triple combination product for management of hypertension, ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) released results from its once-daily vanzacaftor/tezacaftor/deutivacaftor (vanza triple) program for cystic fibrosis ...
In the ongoing battle against antibiotic resistance, a new study published in Engineering by Zhuoren Ling’s research team unveils a promising triple combination of antibiotics that significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results